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C E L L  B I O L O G Y
Reciprocal regulation of TORC signaling and  
tRNA modifications by Elongator enforces  
nutrient-dependent cell fate
Julie Candiracci1, Valerie Migeot1, Yok-Hian Chionh2*, Fanelie Bauer1, Thomas Brochier1, 
Brandon Russell3†, Kazuhiro Shiozaki4,5, Peter Dedon2,3, Damien Hermand1‡
Nutrient availability has a profound impact on cell fate. Upon nitrogen starvation, wild-type fission yeast cells 
uncouple cell growth from cell division to generate small, round-shaped cells that are competent for sexual differ-
entiation. The TORC1 (TOR complex 1) and TORC2 complexes exert opposite controls on cell growth and cell differentia-
tion, but little is known about how their activity is coordinated. We show that transfer RNA (tRNA) modifications 
by Elongator are critical for this regulation by promoting the translation of both key components of TORC2 and 
repressors of TORC1. We further identified the TORC2 pathway as an activator of Elongator by down-regulating 
a Gsk3 (glycogen synthase kinase 3)–dependent inhibitory phosphorylation of Elongator. Therefore, a feedback 
control is operating between TOR complex (TORC) signaling and tRNA modification by Elongator to enforce the 
advancement of mitosis that precedes cell differentiation.
INTRODUCTION
Fission yeast sexual differentiation has evolved as a stress response, 
and almost any sudden change in growth conditions induces some 
cells to accelerate mitosis, become smaller, and enter gametogenesis, 
even in chemostat cultures (1). This is also observed on plated colonies 
where the heterogeneity of nutrient availability generates regions more 
or less conducive to differentiation, which is conveniently induced 
under laboratory conditions by altering, limiting, or withdrawing 
the source of nitrogen (2). More generally, in cultured cells or in 
whole organisms, the critical cell size for mitosis is determined by 
the growth conditions (3, 4). TOR (target of rapamycin) signaling is 
a conserved central mediator of this process. TOR regulates nutrient 
uptake, gene expression, protein synthesis, and metabolic pathways 
to ensure that the balance between cell growth and cell division is 
coordinated with nutrient availability. The process is evolutionarily 
conserved and notably shown in flies grown under nutrient-limiting 
conditions that develop to half of the size of well-fed animals with-
out a reduction of the absolute cell number (3, 4). In fission yeast 
(Fig. 1A), TORC1 (TOR complex 1) defined by the Tor2 kinase and 
the raptor homolog Mip1 is sensitive to rapamycin, promotes cell 
growth, and inhibits entry into mitosis while repressing autophagy 
and cell differentiation. TORC2 defined by the Tor1 kinase and the 
Rictor homolog Ste20 promotes mitosis and is essential for differ-
entiation (5–11). Consequently, TORC1 mutants uncouple nutrient 
availability from growth and have an “always starved” phenotype. 
These mutants eventually arrest as small rounded cell even when 
nitrogen is abundant. In contrast, TORC2 mutants uncouple starvation 
from gametogenesis and have a “never starved” phenotype resulting 
in sterility when nitrogen drops. On the basis of genetic analyses 
and the antagonistic relationship between TORC1 and TORC2, 
the concept of feedback loops connecting both complexes was sug-
gested early on (12) but lacked mechanistic support until recently 
(13, 14).
Transfer RNAs (tRNAs) from all organisms contain modified 
nucleosides, and when a uridine is present in the wobble position 
(U34), this residue is almost universally modified (15–17). In particular, 
the eukaryotic cytosolic tRNALysUUU is thiolated (s2) by the Ctu1 
enzyme at the 2-carbon and contains the most critical methoxy-carbonyl- 
methyl (mcm5) modification  at the 5-carbon on the wobble uridine, 
which is required to offset the translational inefficiency resulting 
from low effective stacking interactions of the A-U base interaction 
(18–20). The six-subunit Elongator complex synthetizes the cm5 
moiety, which becomes a substrate for the Trm9 methylase to generate 
mcm5U (fig. S1A) (21–23). The catalytic subunit of Elongator is 
Elp3. Two copies of the Elp1-Elp2-Elp3 subunits form a two-lobe 
symmetric scaffold, which asymmetrically binds Elp4-Elp5-Elp6. In all 
species where it has been investigated, the absence of any subunits 
results in the inactivation of the whole complex, and mutants show 
an extremely diverse range of phenotypes (24). In fission yeast, a 
major phenotype resulting from the inactivation of Elongator is a 
cell cycle defect, and the cdr2 mRNA that encodes a key regulator of 
mitosis and cytokinesis was shown to harbor a skewed codon content 
for lysine, which places it under translational control by Elongator 
(25, 26). In the present study, we report a reciprocal regulation of 
TOR complex (TORC) signaling and Elongator, showing that tRNA 
modification by Elongator is at the nexus of cell growth and cell 
differentiation.
RESULTS
Our previous proteome-wide analysis of a fission yeast strain lacking 
the Elp3 subunit of Elongator revealed that four distinct functional 
Gene Ontology (GO) groups of proteins were down-regulated (25–27). 
Analysis of the codon usage within the corresponding mRNAs 
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Fig. 1. The Elongator complex regulates the expression of components of TORC1/TORC2 signaling pathways. (A) A schematic of the TORC1 and TORC2 signaling pathways 
in fission yeast. The quality and availability of the nitrogen source control the balance between TORC1 that enforces growth and TORC2 that enforces cell differentiation. 
(B) Top: Average expression level of the proteome in the elp3-deleted strain compared to wild type set to 100%. Average expression level within the GO functional group 
(cellular response to starvation) was significantly more affected than the average in the absence of Elongator (*P < 0.05; **P < 0.01; Student’s t test). Bottom: Codon usage 
for lysine (AAA-AAG), within the GO functional group (cellular response to starvation) compared to the average ORFeome lysine (AAA-AAG) codon usage. Note that the 
0 to 20% and 40 to 100% of the y axis are not shown to highlight variations from the ORFeome codon usage. (*P < 0.05; **P < 0.01; ***P < 0.001; Student’s t test). wt, wild 
type. (C) Hierarchical clustering and heat map analysis of the expression level within the GO functional group (cellular response to starvation) in the ctu1 and elp3 deletion 
strains compared to wild type. The data are presented as log 2 mutant/wild-type ratio of immunoblotting signals and are color-coded as indicated in the key.
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showed a bias for the AAA codon over AAG when encoding lysine, 
which rendered their expression highly dependent on the modification 
by Elongator (26). A detailed analysis of one GO group related to 
the response to nutrients and the TOR signaling pathway highlighted 
the presence of many autophagy-dependent (Atg) proteins, with 
autophagy controlled by the TOR pathway (Fig. 1B). In addition, 
the expression of positive effectors of TORC2 (Tor1, Ste20Rictor, and 
Gad8) and inhibitors of TORC1 (Tsc1, Tsc2, Npr2, and Npr3) was 
also down-regulated in the absence of Elp3 (Fig. 1C and fig. S1B). 
The overexpression of the unmodified tRNALYSUUU was sufficient 
to restore wild-type level of Ste20Rictor and Tsc2 (Fig. 2A) while 
suppressing the rapamycin sensitivity of the elp3 mutant (Fig. 2B), 
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Fig. 2. The Elongator complex regulates the balance between TORC1 and TORC2 activities. (A) Western blot analysis of the level of expression of Ste20-TAP (Tandem 
Affinity Purification) (Rictor in TORC1), Mip1-HA (Raptor in TORC2), and Tsc2 in the indicated strains showing the specific down-regulation of Ste20 and Tsc2 when Elongator 
is inactivated and the rescue when the tRNALYSUUU is overexpressed. Tubulin is used as a loading control. (B) Growth assay of the indicated strains in the presence or 
absence of rapamycin. The tor1 S1834E and tor2 S1837E are rapamycin-resistant alleles. nmt1-tor2 is overexpressing the genes from the nmt1 promoter. EMM, 
Edinburgh minimal medium. (C) Growth assay of the indicated strains in the presence or absence of canavanine. The can1-50 allele harbors a mutation of the canavanine 
transporter Can1, resulting in resistance. nmt1-tor1 and nmt1-tor2 are overexpressing the genes from the nmt1 promoter. (D) Growth assay of the indicated prototrophic 
or auxotrophic strains grown on minimal media supplemented with adenine and uracil.
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supporting a close connection bewteen Elongator and the TORC1/
TORC2 pathways. A broader phenotypic analysis showed that the 
sensitivity of the elp3 mutant to rapamycin was mediated through 
the Fkh1 protein and through the TORC1 complex, as a rapamycin- 
resistant tor2 allele (tor2 S1873E) completely suppressed the 
sensitivity while the corresponding rapamycin-resistant tor1 
allele (tor1 S1834E) did not (Fig. 2B). This set of data suggested that 
the sensitivity of Elongator mutants to rapamycin resulted from the 
increased activity of TORC1 and unbalanced TORC signaling, as 
supported by the fact that the overexpression of tor2 also increased 
the sensitivity to rapamycin (Fig. 2B). In addition, the absence of 
Elongator resulted in resistance to canavanine (Fig. 2C), similar 
to the overexpression of tor2, or the deletion of tsc1, a gene encoding 
hamartin that negatively regulates TORC1 (Fig. 2C). Auxothrophic 
elp3 mutants grew poorly on supplemented minimal media, suggest-
ing a deficient nutrient uptake that is also typical of unbalanced TOR 
signaling in benefit of TORC1 (Fig. 2D). Together, these results sup-
port that Elongator acts as a positive regulator of TORC2 and a negative 
regulator of TORC1 through translational controls of components 
of these complexes and may therefore regulate the balance between 
both complexes.
To test this possibility, we analyzed the behavior of the Elongator 
mutant during nutrient shifts between efficient (glutamate) and poor 
(proline) nitrogen sources, which alters the TORC1/TORC2 balance 
(28–30). Wild-type cells shifted from glutamate to proline were 
advanced into mitosis, as shown by a peak in the percentage of 
dividing cells about 1 hour after the nutritional shift (Fig. 3A). The 
proportion of dividing cells remained largely constant in an Elongator 
mutant (elp4 deletion), indicating that the advancement into mitosis 
was not efficient when Elongator was inactivated. Rapamycin was 
previously shown to mimic the nutritional shift-down (30). The use 
of rapamycin-resistant versions of tor1 and tor2 indicated that the 
mitotic advancement likely occurred by inhibiting TORC1 for the 
benefit of TORC2, as rapamycin had no effect on a strain harboring 
the rapamycin-resistant tor2 S1837E allele (Fig. 3B). In the reverse 
experiment where cells were shifted from the poor nitrogen source 
proline to glutamate, a drop in the percentage of dividing cells was 
observed within 1 hour, indicating a delayed onset of mitosis, which 
restores TORC1-dependent promotion of growth. While the elp4 
mutant barely affected this response, cells remained delayed about 
30 min longer, suggesting TORC1 hyperactivation (Fig. 3C). These 
data support the possibility that the Elongator complex is a critical 
regulator of the balance between the TORC1 and TORC2 complexes 
when environmental cues controlling the commitment to mitosis 
are changing.
To identify regulators of the activity of Elongator, we next set up 
a genetic screen based on dual-color luciferase reporters harboring 
skewed codon content for lysine. We generated a strain expressing 
the green-emitting click beetle luciferase (CBG) expressed from the ura4 
locus and the red-emitting click beetle luciferase (CBR) expressed 
from the leu1 locus (31), which is suitable for Chroma-Glo assays 
carried out directly in the culture medium (fig. S2A). The natural 
codon bias for lysine (CBR: 35% LysAAA/65% LysAAG and CBG: 54% 
LysAAA/46% LysAAG) was sufficient to render their expression sensitive 
to the absence of Elongator, with CBG being the most affected. 
However, CBR was also affected and therefore was not suitable as 
internal control. We therefore modified the reporter strain by using 
a CBGAAG version, where all lysine codons are encoded by the AAG 
codon, and a CBRAAA version, where all lysine codons are encoded 
by the AAA codon. In addition, CBGAAG was fused to the Ade3 
protein, which we have shown to be expressed independently of 
Elongator, and CBRAAA was fused to the Cdr2 protein, which we 
have shown to require Elongator for efficient translation (26). Both 
reporters were stably expressed, and the steady-state levels of their 
mRNAs were independent of the elp3, ctu1, and trm9 genes required 
for the synthesis of the mcm5s2U modification, while the bio-
luminescence of CBRAAA, but not CBGAAG, was affected in the 
absence of these three genes (fig. S2, B to D). The reporter strain was 
crossed to the fission yeast deletion library, and the resulting strains 
were screened for altered dual-color luminescence ratio (fig. S3A). 
An increased or decreased CBR/CBG ratio was found in 417 clones, 
suggesting that the translation of the reporter of Elongator activity 
can be either up- or down-regulated (table S1). Considering this 
large number of candidates and the possibility of cell cycle effects 
resulting from using the Cdr2 fusion, the positive clones were 
screened for altered expression of Atf1, another well-characterized 
but unrelated target of Elongator (32). The set of 100 clones that 
behaved similarly in both screens was further analyzed. We found 
that the tsc1, tor1, and ekc1 genes encoding key players of the TOR 
pathways were recovered in both screens, and this list was further 
extended to tsc2, npr2, ste20, and hhp2 when considering only 
screen 1 (fig. S3B). The casein kinase Hhp2 (Hrr25) and the Ekc1 
(Sit4) phosphatase subunit were previously shown to be required 
for the activity of Elongator in budding yeast (fig. S3C) (23, 33), 
further validating the screens. The fact that inhibitors of TORC1 (Tsc1, 
Tsc2, and Npr2) and components of TORC2 (Tor1 and Ste20) were 
identified as positive regulators of Elongator suggested that, while 
Elongator is required for proper balance between TORC1 and 
TORC2, TORCs could in turn regulate the synthesis of the modifi-
cation by Elongator (fig. S3C).
To explore this possibility, we first adapted the previously de-
scribed liquid chromatography–coupled mass spectrometry (LC-MS) 
quantitative approach (34) to fission yeast. Analysis of the elp3 and 
ctu1 single mutants and the double elp3/ctu1 mutant confirmed our 
previous work (35) showing the loss of canonical Elongator-dependent 
modifications in the absence of elp3 and the specific loss of s2 when 
ctu1 is deleted, while a set of unrelated modifications was barely 
affected (Fig. 4A). We next focused on the complete set of detectable 
modified nucleosides dependent on Elongator activity (fig. S1A) 
and analyzed them in strains overexpressing either tor1 or tor2 or 
grown in the presence of rapamycin. This experiment revealed that 
the inhibition of TORC1 by rapamycin or the overexpression of the 
TORC2 kinase Tor1 resulted in an increase in the cm5U and cm5Um 
nucleotides, while the overexpression of the TORC1 kinase Tor2 
had the opposite effect (Fig. 4A and fig. S4, A to C). These data 
indicate that the artificial manipulation of TOR signaling affects the 
level of the Elongator-dependent modifications, with TORC1 and 
TORC2 showing an opposite effect. The increased levels of cm5U 
or cm5Um are reminiscent of the deletion of trm9, suggesting that 
the methylase may become limiting when Elongator activity is 
increased.
Phosphoproteome-wide analyses in budding yeast have highlighted 
that the Elp4 subunit of Elongator undergoes rapamycin-dependent 
phosphorylation on serine-221 (36). The same region in fission yeast 
Elp4 (fig. S5A) was reported to be phosphorylated in two independent 
large-scale analyses (37, 38). In this latter case, the targeted sites are 
S114 and S118 in the S114S115P116P117S118 sequence, which are 
conserved within the fission yeast clade (fig. S5B). In addition, the 
 o
n
 July 10, 2019
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Candiracci et al., Sci. Adv. 2019; 5 : eaav0184     19 June 2019
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
5 of 13
A 
wt glu → pro 
elp4  glu → pro 
D
iv
id
in
g 
ce
lls
 (%
) 
0 
5 
10 
15 
20 
25 
30 
35 
40 
45 
0 30 60 90 120 
0 
5 
10 
15 
20 
25 
30 
35 
40 
0 30 60 90 120 
0 
5 
10 
15 
20 
25 
30 
35 
0 30 60 90 120 0 
5 
10 
15 
20 
25 
30 
35 
0 30 60 90 120 
0 
2 
4 
6 
8 
10 
12 
14 
0 30 60 90 120 0 
2 
4 
6 
8 
10 
12 
14 
0 30 60 90 120 
B 
C 
wt glu → glu 
elp4  glu → glu 
tor1 S1834E + rapamycin 
wt + rapamycin 
tor2 S1837E + rapamycin 
wt pro → glu 
elp4  pro → glu 
wt pro → pro 
elp4  pro → pro 
D
iv
id
in
g 
ce
lls
 (%
)
D
iv
id
in
g 
ce
lls
 (%
) 
D
iv
id
in
g 
ce
lls
 (%
)
D
iv
id
in
g 
ce
lls
 (%
) 
D
iv
id
in
g 
ce
lls
 (%
) 
Time (min) Time (min) 
Time (min) Time (min) 
Time (min) Time (min) 
TORC1 TORC2 
Glutamate          Proline 
0  30  60  90 120 min 
TORC1 TORC2 
Rapamycin 
0  30  60  90 120 min 
TORC2 TORC1 
Proline          Glutamate 
0  30  60  90 120 min 
Fig. 3. The Elongator complex is required for the nutrient-dependent shift between the TORC1 and TORC2 complexes. (A) The percentage of dividing cells was 
determined during a shift from an efficient (glutamate) and a poor (proline) nitrogen source in wild-type or Elongator-deficient strains. A glutamate-to-glutamate shift is 
shown as control. Each column represents the averaged value ± SEM (n = 3). Right: Averaged values for clarity. Note that an elp4 mutant was used, as Elp4 will be the focus 
of the rest of the manuscript, but that the deletion of any subunit of Elongator results in the inactivation of the whole complex. (B) The percentage of dividing cells was 
determined after addition of rapamycin that mimics the mitotic advancement following a nutritional shift. The indicated strains including rapamycin-resistant alleles of 
tor1 and tor2 were used. Each column represents the averaged value ± SEM (n = 3). Right: Averaged values for clarity. (C) The percentage of dividing cells was determined 
after a shift from a poor (proline) to an efficient (glutamate) nitrogen source in wild-type or Elongator-deficient strains. A proline-to-proline shift is shown as control. Each 
column represents the averaged value ± SEM (n = 3). Right: Averaged values for clarity.
 o
n
 July 10, 2019
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Candiracci et al., Sci. Adv. 2019; 5 : eaav0184     19 June 2019
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
6 of 13
A 
Cm 
R
a
p
a
m
y
c
in
m1A 
m5U 
D 
mcm5S2U 
m5C 
Um 
m1G 
m22G 
m7G 
m62A 
ac4C 
m2G 
s2U 
aM 
m1I 
i6A 
yW 
Gm 
I 
m2A 
mcm5U 
ncm5U 
t6A 
ncm5U 
cm5U 
cm5Um 
ncm5Um 
cm5s2U 
mcm5Um 
mcm5U 
mcm5s2U 
B 
U
n
m
o
d
if
ie
d
 
S
1
1
8
E
 
S
1
1
5
A
 S
1
1
8
P
 
S
1
1
4
A
 S
1
1
8
P
 
Gsk3-flag IP + elp4 peptide 
130 kDa 
95 kDa 
72 kDa 
55 kDa 
36 kDa 
C 
Elp4 
Gsk3 
+ + –
Elp4 + – – +
Elp4 S114A – + –
Gsk3 Gsk3 +++ –
Elp4      + – – +
Elp4 S114A – + – –
Gsk3
Elp4
55 kDa 
36 kDa 
72 kDa 
55 kDa 
D 
Fig. 4. The TORC1/TORC2 pathway controls the level of the Elongator-dependent modifications. (A) Left: Hierachical clustering analysis of changes in the relative 
levels of a set of tRNA ribonucleoside modifications in mutants of genes required for the synthesis of wobble s2 (ctu1) and mcm5 (elp3) uridine moieties. The bottom 
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yeast Elp4 harboring the indicated mutations or phosphorylation (S118P) using immunoprecipitated Gsk3-flag. (C) Phosphorylation assay of endogenous immunoprecip-
itated Elp4-TAP protein (wt or S114A as indicated) mixed with immunoprecipitated Gsk3-flag before the kinase assay. The band corresponding to Elp4 (40 kDa) is indicated 
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deletion of the elp4 gene in Schizosaccharomyces japonicus also 
resulted in increased sensitivity to rapamycin, which supports a 
conservation of the TOR-Elongator connection (fig. S5C). Serine-114 
constitutes a glycogen synthase kinase 3 (Gsk3) consensus site, as 
this kinase requires a priming phosphorylation at the +4 residue. 
These findings were of interest, as Gsk3 is known to be negatively 
regulated by the Akt kinase downstream of the TORC pathway (39, 40).
We first tested the ability of Gsk3 to phosphorylate an Elp4 peptide 
encompassing the targeted region. Immunoprecipitated Gsk3 only 
phosphorylated the Elp4 peptide prephosphorylated at position 118 and 
harboring a serine at position 114, which confirmed the dependency 
of Gsk3 for a priming phosphorylation at +4 (Fig. 4B). To test the 
ability of Gsk3 to phosphorylate the endogenous Elp4, we precipitated 
Gsk3 and Elp4 from fission yeast cells and mixed the precipitated 
products for a subsequent kinase assay. Gsk3 phosphorylated multiple 
proteins from the Elp4 immunoprecipitation (IP), with one band 
fully dependent on the presence of a serine at position 114 on Elp4 
(Fig. 4, C and D). Together, these data strongly support that Elp4 is 
a target of Gsk3 in fission yeast.
We next confirmed that the fission yeast Akt kinase Gad8 phospho-
rylated the fission yeast Gsk3 in vitro using a recombinant glutathione 
S-transferase (GST)–Gsk3 as a substrate. A previous study had 
identified S335 as a major, albeit not unique, inhibitory phosphorylated 
site (41), and the phosphorylation of Gsk3 by Gad8 was indeed 
reduced when a GST-Gsk3 S335A protein was used as a substrate 
(fig. S6, A to C). These data supported a conservation of the TOR → 
Akt → Gsk3 connection in fission yeast. Moreover, recombinant 
GST-Gsk3 harboring a S335E mutation was less active than the 
wild-type version (fig. S6D). In addition, the activity of Gsk3 on Elp4 
was increased in a gad8 mutant (fig. S6D) and strongly decreased 
when nitrogen was removed (fig. S6E), a condition known to activate 
the TORC2-Gad8 branch of the TOR pathway. Despite the fact that, 
in this case, the level of the Gsk3 protein dropped, the expected net 
consequence is a decreased phosphorylation of Elp4 on S114.
To analyze the consequence of Elp4 phosphorylation, we generated 
unphosphorylatable and phospho-mimic S114 and S118 versions 
of Elp4 and examined their phenotypes. As an intermediate step in 
creating the elp4 mutant, we generated a strain disrupted for elp4 by 
retaining only the first 91 amino acids. Unexpectedly, this truncated 
version behaved as a dominant negative, as the expression of wild-type 
elp4 could not fully complement the rapamycin sensitivity of the 
strain (Fig. 5, A and B). The S114A mutant grew much better than 
the wild type, bypassing the dominant-negative phenotype, which 
suggested that the S114 phosphorylation by Gsk3 is inhibitory and 
that its removal in the S114A mutant generates a hyperactive version 
of Elongator. In contrast, mutating S114, the phospho-mimic 
glutamic acid, decreased the ability of the strain to grow in the presence 
of rapamycin (Fig. 5B), suggesting a negative effect of the phospho-
rylation. The status of position 114 directly affected the level of the Elp4 
protein (Fig. 5C), which is a typical feature of Gsk3-phosphorylated 
sites (42). The effect of mutating S118 was less clear and difficult to 
interpret, as either alanine or glutamic acid versions behaved closer 
to the wild type with a clear stabilization of the protein. In addition, 
the kinase phosphorylating S118 is unknown, and we therefore 
focused on the S114 site.
We next analyzed the effect of the Elp4 S114A mutation on the 
TORC1 and TORC2 complexes using the level of phosphorylation 
of Psk1 (43) and Gad8 as specific reporters of the activity of these 
complexes (Fig. 5D and fig. S7). This experiment revealed that the 
Elp4 S114A mutation has an opposite effect on TORC1 (Psk1) and 
TORC2 (Gad8) in favor of TORC2 activity. Similar to a TORC2 
mutant, an elp4 mutant is defective for gametogenesis (Fig. 5E). The 
defect was complemented by the S114A version of Elp4, confirming 
the close relationship between Elongator and TORC2. Together, 
these data suggest that the S114 phosphorylation of Elp4 decreases 
the activity of Elongator.
We further tested this possibility using LC-MS to measure the 
impact of the S114 phosphorylation on the subset of Elongator- 
dependent modifications. The S114A mutation behaved as a deletion 
mutant of gsk3, mostly resulting in an increase of the major Elongator- 
dependent modified nucleotides (Fig. 6A). A previous study in fission 
yeast reported that the Ppe1 phosphatase opposes Gsk3 (44). We 
therefore tested the ppe1 mutant in the same setup, which indicated 
that it behaved oppositely to Gsk3 and was required for proper level 
of the Elongator-dependent modifications (Fig. 6A). It will therefore 
be of interest to test whether Ppe1 can directly dephosphorylate Elp4 
when an assay becomes available. To get a condition where rapamycin 
affects the growth of fission yeast, we combined it with caffeine as 
previously reported (45). Under these conditions, the behavior of 
the gsk3 mutants was again opposite to that of the ppe1 mutant, 
showing slow growth reminiscent of an elp4 mutant, while the deletion 
of gsk3 suppressed the growth defect of the wild type (Fig. 6B). In 
addition, the Elp4 S114A mutant substantially suppressed the growth 
defect of the ppe1 deletion strain on rapamycin (Fig. 6B).
Together, these data indicate that TORC2 negatively regulates 
Gsk3 and that, in turn, Gsk3 negatively regulates Elongator through 
the phosphorylation of Elp4 S114, while Ppe1 likely opposes this 
phosphorylation. In that context, the structural partner of Ppe1, 
Ekc1 (46), behaved as an activator of Elongator in the genetic screen 
described in fig. S3. These data also provide a mechanistic view of 
the role of Elongator in regulating the nutrient-dependent switch 
between TORC1 and TORC2, as presented in the model shown in 
fig. S9. To further test this model, we directly analyzed the effect of 
the deletion of gsk3 or the inactivation of Elongator on the activities 
of TORC1 and TORC2 using the phosphorylation of Psk1 and Gad8 
as direct specific reporters of TOR signaling (47, 48) (Fig. 6, C and D, 
fig. S8, and table S2). Within an hour, nitrogen starvation leads to 
the switch from high TORC1 activity to high TORC2 activity. In the 
absence of Gsk3, while the inactivation of TORC1 occurred normally, 
the phosphorylation of Gad8 increased 30 min earlier. The absence 
of Elp4 led to an opposite effect with persistent TORC1 activity and 
the inability to activate TORC2. In the reciprocal experiment in 
which nitrogen is added to starved cells, high TORC2 activity de-
creased within 30 min, in addition to an increase in TORC1 activity. 
In the absence of Gsk3, the activation of TORC1 was delayed by 
about 30 min with persistent TORC2 activity. In the absence of 
Elongator, TORC1 activity was still detected even during nitrogen 
starvation and quickly increased when nitrogen was added, while 
the activity of TORC2 was barely detectable during the entire course 
of the experiment.
DISCUSSION
This work shows that, by promoting the translation of Tor1 and 
Ste20 among others, Elongator is a critical activator of the TORC2 
complex. In turn, TORC2 releases the inhibitory phosphorylation 
of Elp4 by Gsk3, therefore creating a positive TORC2-Elongator 
feedback loop, which is required for the nutrient-dependent control of 
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mitosis onset and cell fate (fig. S9). In contrast, Elongator negatively 
controls TORC1 by sustaining the translation of negative regulators 
of the complex including the hamartin Tsc1 and Tsc2. Recent work 
has revealed that the Ppe1-Eck1 phosphatase is inhibited by TORC1 
(49). Here, we have identified Eck1, an activating subunit of Ppe1, 
as an activator of Elongator. Together with previous data indicating 
that Ppe1 counteracts Gsk3 in fission yeast (44), the possibility that 
Ppe1 dephosphorylates Elp4 on S114 exists, therefore creating a 
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Fig. 5. The S114A mutant is the hyperactive version of Elp4. (A) A schematic of the disrupted allele retaining the first 91 amino acids of Elp4. bp, base pair. (B) Growth 
assay of the elp4 disruption strain transformed with plasmids expressing the indicated wild-type or elp4 mutants or an empty vector (ctr) in the presence or absence 
of rapamycin. (C) Western blot analysis of the level of expression of the indicated elp4 mutants. Tubulin is used as a loading control. (D) Western blot analyses of the 
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in the indicated homothallic elp4-deleted strain transformed with plasmids expressing the indicated wild type, elp4 S114A mutant, or an empty vector (ctr). Clones were 
grown on low-nitrogen medium for 48 hours. The dark iodine staining indicates the presence of gametes (asci) as confirmed by 4′,6-diamidino-2-phenylindole (DAPI) 
staining. The mating efficiency is indicated as percentage.
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negative TORC1-Elongator feedback loop, which we are currently 
investigating.
The central position of Elongator as a regulator of the balance 
between TORC1 and TORC2 is also supported genetically. Similar 
to strains with hyperactive TORC1, Elongator mutants display 
resistance to canavanine, slow growth when bearing auxotrophic 
markers, defect in gametogenesis, and the inability to adapt cell size in 
response to change in the nitrogen source (11). Elongator mutants 
also share some phenotypes with TORC2 inactivation including 
moderate cell elongation and misplaced septa (50). In addition, it 
was previously noted on that the levels of Ste20 and Sin1, two 
components of TORC2, are reduced when the TORC1 kinase Tor2 
is overexpressed (6), which likely reflects the fact that Elongator is 
down-regulated under these conditions.
cm5U 
cm5Um 
ncm5Um 
mcm5Um 
ncm5U 
mcm5U 
cm5s2U 
mcm5s2U 
m3Y 
A B 
DMSO Rapamycin 
caffein 
elp4
ctr 
gsk3
ppe1
Psk1-P 
Gad8-P 
wild type 
0             30           60            90 
Psk1-P
Gad8-P
wild type
0             15           30            60 
TORC1 TORC2 TORC2 TORC1 
Psk1-P 
Gad8-P 
gsk3
0             30           60            90 
TORC1 TORC2 
Psk1-P
Gad8-P
gsk3
0             15           30            60 
TORC2 TORC1 
Psk1-P 
Gad8-P 
elp4
0             30           60            90 
TORC1 TORC2
Psk1-P
Gad8-P
elp4
0             15           30            60 
TORC2 TORC1
C D 
 
Ph
os
ph
or
yla
tio
n 
le
ve
l (%
)
Ph
os
ph
or
yla
tio
n 
le
ve
l (%
)
Ph
os
ph
or
yla
tio
n 
le
ve
l (%
)
Ph
os
ph
or
yla
tio
n 
le
ve
l (%
)
Ph
os
ph
or
yla
tio
n 
le
ve
l (%
)
Ph
os
ph
or
yla
tio
n 
le
ve
l (%
)
0 
10 
20 
30 
40 
50 
60 
70 
-10 
0 
10 
20 
30 
40 
50 
60 
0 
10 
20 
30 
40 
50 
60 
0 
10 
20 
30 
40 
50 
60 
0 
10 
20 
30 
40 
50 
60 
0 
10 
20 
30 
40 
50 
60 
ppe1
ppe1 elp4 S114A
DMSO Rapamycin 
Fig. 6. The balance between TORC1 and TORC2 pathways is regulated by Elongator. (A) Cluster analysis visualization of changes in the relative levels of all detectable 
Elongator-dependent modified ribonucleosides in the indicated strains. The bottom color bar displays the range of log 2 fold change values. (B) Growth assay of the 
indicated strain in the presence of rapamycin/caffeine (top), rapamycin (bottom), or vehicle. DMSO, dimethyl sulfoxide. (C) Phosphorylation level of the TORC1 substrate 
Psk1 and the TORC2 substrate Gad8 during nitrogen starvation. Cells were filtered and resuspended in a medium deprived of nitrogen at time 0 and analyzed for 90 min 
in the indicated strains. Each point represents the averaged normalized value ± SEM (n = 3). (D) Phosphorylation level of the TORC1 substrate Psk1 and the TORC2 
substrate Gad8 after addition of nitrogen on cells starved for 2 hours. Cells were filtered and resuspended in a medium deprived of nitrogen for 2 hours. Nitrogen (NH4CL) 
was added back at time 0, and indicated strains were analyzed for 60 min. Each point represents the averaged normalized value ± SEM (n = 3).
 o
n
 July 10, 2019
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Candiracci et al., Sci. Adv. 2019; 5 : eaav0184     19 June 2019
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
10 of 13
Both TORCs also critically regulate the level of Elongator- dependent 
tRNA modifications, as shown by MS-based analyses of modified 
uridine in strains overexpressing either tor1 or tor2 (Fig. 4A). 
Although it was anticipated that Elongator could be regulated on the 
basis of the phosphorylation of Elp1 (33), and despite the require-
ment of the Hrr25 kinase and the Sit4 phosphatase for the synthesis 
of the mcm5 modification (23), our work shows that tRNA modifi-
cation by Elongator not only is a basic requirement for proteome 
integrity (51) but also is regulated by the central growth control ma-
chinery of the eukaryotic cell.
The mechanism of the control of Elongator by TORC2 relies on 
a critical phosphorylation of Elp4, which is regulated by the TORC2-
Gad8 branch of the TOR pathway through Gsk3. The site is conserved 
within the fission yeast clade, and a closely related position was 
shown to undergo TOR-dependent phosphorylation in the distantly 
related species Saccharomyces cerevisiae (36), which suggests that 
the phosphorylation we report here likely plays a major conserved 
function. The S114 and flanking consensus are located within a 
region with overall low conservation that was shown to make intimate 
contacts with both Elp1 and Elp3 (52), which may underlie its 
importance. Moreover, the fact that two Elp4-Elp5-Elp6 subcom-
plexes can be loaded onto the Elp1-Elp2-Elp3 two-lobe symmetric 
scaffold may allow the possibility of double rate synthesis of tRNA 
modification under some conditions, and the phosphorylation of 
Elp4 could be critical for this regulation. The Elp4 S114 phospho-
rylation site is found within a Gsk3 consensus, and our data indeed 
show that it requires prephosphorylation at the +4 position (S118). 
In addition, an S114A mutation markedly stabilizes Elp4, which is 
another well-conserved feature of Gsk3 substrates (42). As the 
phosphorylation of S118 is a prerequisite for efficient S114 phos-
phorylation, one may anticipate that a S118A mutant would be-
have similarly to a S114A mutant. However, the S118A mutant 
rather behaved as the wild type (Fig. 5B). One cannot exclude 
that S118 phosphorylation has a function on its own, as suggested 
by the detrimental effect of the S118E mutation, which complicates 
the interpretation of the behavior of the S118 mutant.
Our data also support that Gsk3 is itself phosphorylated by Gad8, 
which negatively regulates its activity. This may occur at S335, whose 
phosphorylation was previously shown to decrease the activity of 
Gsk3 in fission yeast (41). However, this site is not in a perfect Akt-Gad8 
consensus, but additional consensus sites, including S282, are present 
and were not tested here. In addition, the level of Gsk3 phosphoryl-
ation by Gad8 in vitro remains weak, which may indicate that the 
assay is not optimal or that additional kinases function in vivo.
Genome-wide screens for rapamycin sensitivity in fission yeast 
have shown that the phenotype is not common but specific to Elongator 
mutants (53). Our data show that the sensitivity depends on Tor2, 
as a tor2-resistant allele but not a tor1-resistant allele bypasses it. A 
possibility to explain the sensitivity of Elongator mutant to rapamycin 
is that, upon addition of the compound, TORC1 activity is decreased 
but TORC2 cannot be activated because of the low level of Ste20 
and Tor1. The resulting uncoordinated TOR activity would be 
lethal. It was previously reported that a tor1/tor2 double mutant is 
not viable despite the opposite functions of both complexes (11). 
Therefore, the concomitant decrease of TORC1 and TORC2 activi-
ties when Elongator mutants are grown on rapamycin could simi-
larly result in lethality.
Rapamycin mimics the shortening of the cell cycle that results 
from a change in the nitrogen source that affects cell fate. The present 
work shows that Elongator is essential for that process and functions 
as a central coordinator of the nutrient-dependent control of cell 
division and cell fate. These findings shed new light on the increasing 
reports of prominent roles of Elongator in tumorigenesis (54–56).
MATERIAL AND METHODS
Fission yeast methods
Wild-type and mutant strains listed in table S4 were grown at 32°C 
in Edinburgh minimal medium (EMM) with indicated nitrogen 
source. For starvation, cells were filtered from EMM to the indicated 
medium using the following nitrogen sources: NH4CL (90 mM), 
glutamate (20 mM), and proline (10 mM). Rapamycin was used at 
25 ng/ml on plates and at 300 ng/ml in liquid cultures. Caffeine was 
used at 100 g/ml. Canavanine was used at 75 g/ml. Fission yeast 
growth, gene targeting, including locus-specific integration, and 
mating were performed using classical methods (57–59). Western 
blot was performed with anti-hemagglutinin (HA; H6908, Sigma- 
Aldrich), peroxidase-antiperoxidase (PAP) (P1291, Sigma-Aldrich), anti- 
tubulin (T5168, Sigma-Aldrich), anti-Flag (F3165, Sigma-Aldrich), 
anti-myc (MMS-150P, Covance), anti–phospho–S546-Gad8 (60), 
and anti–phospho-p70 S6 kinase [Phospho-Psk1; 9206, Cell Signaling 
Technology (43)] antibodies. For the secondary screen based on 
Atf1-HA level, fluorescent Western blotting was performed for nor-
malization using the following antibodies: anti-HA (MMS-101P, 
Covance), anti-tubulin (T5168, Sigma-Aldrich), and secondary 
antibody anti-mouse immunoglobulin G IRDye 800CW (610-631-002, 
Rockland), and each signal was analyzed using LI-COR scanner 
following the instructions of the manufacturer. Ratio of mutant signal 
to wild-type signal is calculated. Iodine staining was performed by 
exposing 48 hours crosses to iodine (25).
The deletion of elp4 in S. japonicus was performed by electropo-
ration using a polymerase chain reaction (PCR) product flanked by 
long homology arms generated by a three-step PCR as previously 
described (61, 62). Mutageneses were performed using the Q5 Site- 
Directed Mutagenesis Kit (New England BioLabs). Overexpression 
of tRNA from plasmids was performed as previously described (26). 
Protein arrays were performed as previously described (27). The 
various versions of elp4 were expressed from the plasmid pJK148-
ars1, including the endogenous elp4 promoter: pDH731 (elp4), 
pDH733 (elp4 S114A), pDH735 (elp4 S118A), pDH749 (elp4 
S114E), pDH776 (elp4 S118E), and pDH729 (empty vector).
Northern blot
Total RNA was prepared by phenol extraction (63) and purified on 
Qiagen RNeasy. Total RNA (15 to 30 g) was separated on gel and 
transferred on nitrocellulose. Hybridization of a multiprime-labeled 
probe covering indicated positions was performed overnight at 
42°C. Quantitative reverse transcription PCR was performed using 
the ABI High-Capacity RNA-to-cDNA Kit following the instructions 
of the manufacturer. The untreated sample was used as a reference, 
and ribosomal RNAs were used as loading controls.
IP-kinase assay
IPs were performed as previously described (64): Cells were disrupted 
with a Fastprep (MP) Biomedicals, and proteins were precipitated 
on appropriately coated Dynabeads (Invitrogen) following the in-
structions of the manufacturer for 2 hours and washed four times in 
NP-40 buffer [6 mM Na2HPO4, 4 mM NaH2PO4, 1% Nonidet P-40, 
 o
n
 July 10, 2019
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Candiracci et al., Sci. Adv. 2019; 5 : eaav0184     19 June 2019
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
11 of 13
150 mM NaCl, 2 mM EDTA, and 50 mM NaF supplemented with 
complete EDTA-free and PhosSTOP tablets (Roche)] and once 
in kinase buffer [10 mM MgCl2, 50 mM tris-HCl (pH 7.5), 2 mM 
dithiothreitol, 1 mM EDTA, and 1 mM EGTA] before the kinase 
reaction in kinase buffer supplemented with 1 l of 32P-ATP 
(adenosine triphosphate; 3000 Ci/mmol), 100 M ATP, and 1 g of 
Elp4 peptide (corresponding to 1 l). Peptides were synthetized by 
Eurogentec with the following sequences: Elp4, SAGEDNHSSPPSKN; 
Elp4, S118-P SAGEDNHSSPPS(Ph)KN; Elp4, S114A S118-P 
SAGEDNHASPPS(Ph)KN; and Elp4, S115A S118-P SAGEDNHSAPPS 
(Ph)KN. The assay was performed for 30 min at 30°C and separated on 
tris-Tricine gel (Bio-Rad). GST-Gsk3 fusion proteins were expressed 
from pGEX4T1 and purified following the instructions of the 
manufacturer (GE Healthcare).
Chroma-Glo assay
Yeast were inoculated in 96-well plate in EMM containing amino 
acids, nucleobases, and thiamine (15 M) for at least 20 hours 
before shifting in same medium without thiamine for 16 hours. 
Thirty microliters of culture was dispatched on a new 96-well plate 
and mixed with an equal volume of Chroma-Glo reagent. Plate was 
placed in Berthold and incubated at 30°C for 45 min. Luminescence 
was measured at 510 and 620 nm. Total luminescence was measured 
only for experimental tuning because the same filters are used for all 
screened plates.
Calibration constants were determined by the following measure-
ments of cells expressing only CBR or CBG68, and the Chroma-Luc 
calculator used to determine corrected luminescence values is available 
at: www.promega.com: R, total red luminescence measured from 
CBR without filter; G, total green luminescence measured from 
CBG68 without filter; Rrf, red luminescence measured from CBR 
with red filter (610 long-pass filter); Grf, green luminescence 
measured from CBG68 with red filter (610 long-pass filter); Rgf, red 
luminescence measured from CBR with green filter (510/60 nm 
filter); and Ggf, green luminescence measured from CBG68 with 
green filter (510/60 nm filter). Corrected red luminescence value 
(R0) and green luminescence value (G0) were determined following 
the instructions of the manufacturer.
G′ corresponds to the corrected signal of internal standard 
Ade3-CBGAAG, and R′ corresponds to the Elongator-sensitive reporter 
Cdr2-CBRAAA. The R′/G′ ratio is measured for all single-deletion/
dual-reporter strains and compared to the wild-type ratio.
Quantification of Psk1 and Gad8 phosphorylation level and 
statistical analyses
Quantifications were performed by ImageJ on three replicates. Each 
point represents the averaged normalized value ± SEM (n = 3). The 
raw data and normalizations are presented in table S2. For this 
experiment (Fig. 6), we preferred to use the myc-tag version rather 
than the anti–phospho-p70 S6 used in Fig. 5D, which gave more 
diffused bands.
Quantification of tRNA modifications
Modified ribonucleosides in tRNA were identified and quantified, as 
previously reported (34, 65, 66). Total RNAs were extracted and enriched 
in small RNAs (<200 nt, >85% tRNA) using the PureLink miRNA 
Isolation Kit (Invitrogen). The quantity of tRNA was then determined 
by ultraviolet spectrophotometer at 260 nm and Agilent Bioanalyzer 
analysis (small RNA kit). Using identical quantities of tRNA from 
various strains, each sample was mixed with (15N)5-2-deoxyadenosine 
as internal standard, and the tRNAs were enzymatically hydrolyzed 
using 1 g of coformycin, 4 mM butylated hydroxytoluene, 5 g 
of tetrahydrouridine, 8.5 mM MgCl2, 85 mM tris (pH 7.9), 25 U 
of Benzonase, 0.2 U of phosphodiesterase, and 5 U of alkaline 
phosphatase and incubated at 37°C for 3 hours. The enzymes and 
other large molecules were removed by ultrafiltration.
The digested ribonucleosides were resolved on a Thermo Hypersil 
GOLD aQ column (100 mm by 2.1 mm; particle size, 1.9 m) 
in a two-buffer eluent system, with buffer A consisting of water 
with 0.1% (v/v) formic acid and buffer B consisting of acetonitrile 
with 0.1% (v/v) formic acid. High-performance liquid chroma-
tography (HPLC) was performed at a flow rate of 0.3 ml/min. 
The gradient of acetonitrile in 0.1% formic acid was as follows: 
0 to 12 min, held at 0%; 12 to 15.3 min, 0 to 1%; 15.3 to 18.7 min, 
1 to 6%; 18.7 to 20 min, 6%; 20 to 24 min, 6 to 100%; 24 to 27.3 min, 
100%; 27.3 to 28 min, 100 to 0%; and 28 to 41 min, 0%. The HPLC 
column was maintained at 25°C and directly connected to an 
Agilent 6490 triple quadrupole ion funnel mass spectrometer 
(LC–tandem MS) with ESI Jet Stream ionization operated in positive 
ion mode. Modified ribonucleosides were identified by HPLC 
retention time and collision-induced dissociation fragmentation 
pattern. Multiple reaction monitoring was performed to detect and 
quantify the ribonucleosides with the parameters of retention time, 
mass/charge ratio (m/z) of the transmitted parent ion, and m/z of 
the monitored product ion and dwell time, as noted below. Collision 
energies and cell accelerator voltages were optimized on the basis of 
commercial standards. The fragmentor voltage was fixed at 380 V, 
with MS1 and MS2 filters set at unit resolution. The voltages 
and source parameters were as follows: gas temperature, 50°C; gas 
flow, 11 liters/min; nebulizer, 20 psi; sheath gas temperature, 300°C; 
sheath gas flow, 12  liters/min; capillary voltage, 1800 V; and 
charging voltage 2000 V.
The signal intensity for each ribonucleoside was normalized 
with the signal intensity of the spike-in standard, and abundance of 
the modified ribonucleosides was compared to the control. The 
spike-in standard and canonical ribonucleosides (A, U, G, and C) 
varied between 7 and 17% across all samples, suggesting that run-to 
run variation due to sample handling and day-to-day machine 
fluctuation were kept to a minimum. The raw data used to generate 
the clusters shown in Figs. 4A and 6A are presented in table S3.
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Table S3. Raw and processed data of the quantification of tRNA modifications used to build 
Figure 3A, left (sheet 1), 3A, right (sheet 2), and 4A (sheet 3).
Table S4. List of strains used and generated in this study.
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